News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
ACREOL Global – Advancing the Frontlines of Palliative Care: Elekta Foundation Partnership
ACREOL Global/X
Jun 13, 2025, 06:04

ACREOL Global – Advancing the Frontlines of Palliative Care: Elekta Foundation Partnership

ACREOL Global posted on X:

“Advancing the Frontlines of Palliative Care: Elekta Foundation partnership!
In collaboration with Elekta Foundation, we are strengthening Palliative Care services by equipping healthcare professionals with the knowledge and skills they need to deliver compassionate, patient-centered care.”

More posts featuring Elekta Foundation.

ACREOL Global cancer Elekta Foundation OncoDaily Oncology Palliative Care
Special Coverage
Blog
Jun 13, 2025, 06:04
ACREOL Global - Advancing the Frontlines of Palliative Care: Elekta Foundation Partnership
Science
Jun 13, 2025, 05:57
Dana-Farber’s Breast Oncology Center - Accuracy and Reproducibility of ChatGPT Responses to Breast Cancer Tumor Board Patients
Blog
Jun 13, 2025, 05:44
Galip Can Uyar: Telehealth-Delivered Geriatric Assessment Makes a Difference
Blog
Jun 13, 2025, 05:35
Jorge Cortes: The First Issue of Blood Global Hematology is Out
Insight
Jun 13, 2025, 05:15
Yuji Uehara: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC
Insight
Jun 13, 2025, 04:29
MD Anderson Research Highlights
Drugs
Jun 13, 2025, 04:16
Pemigatinib (Pemazyre): Uses in Cancer, Side effects, Dosage, Expectation and more
Insight
Jun 13, 2025, 03:49
Diego A. Díaz García shared an article on roles of the gut microbiota in immune-related adverse events - mechanisms and therapeutic intervention
Oncolibrary
Jun 13, 2025, 03:18
Etiology: Understanding the Causes and Origins of Disease
Insight
Jun 12, 2025, 19:31
Amar Kishan: UCLA Launches ILLUSION Trial on 2 mm PTV Margins in CT-Guided SBRT
Insight
Jun 12, 2025, 19:16
Eric K. Singhi: U.S. FDA Approved Taletrectinib for ROS1+ mNSCLC
Insight
Jun 12, 2025, 19:07
Rami Manochakian: FDA Approves Taletrectinib for ROS1-Positive Non-Small Cell Lung Cancer Based on TRUST Trials